Literature DB >> 27668044

Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia.

Lisa A Raedler.   

Abstract

Entities:  

Year:  2016        PMID： 27668044      PMCID： PMC5013847     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  4 in total

Review 1.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

2.  The economic burden of schizophrenia in the United States in 2002.

Authors:  Eric Q Wu; Howard G Birnbaum; Lizheng Shi; Daniel E Ball; Ronald C Kessler; Matthew Moulis; Jyoti Aggarwal
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

3.  A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.

Authors:  Herbert Y Meltzer; Robert Risinger; Henry A Nasrallah; Yangchun Du; Jacqueline Zummo; Lisa Corey; Anjana Bose; Srdjan Stankovic; Bernard L Silverman; Elliot W Ehrich
Journal:  J Clin Psychiatry       Date:  2015-08       Impact factor: 4.384

Review 4.  Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Authors:  Hiram Joseph Wildgust; Mike Beary
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153
  4 in total
  5 in total

Review 1.  Lipid-Drug Conjugate for Enhancing Drug Delivery.

Authors:  Danielle Irby; Chengan Du; Feng Li
Journal:  Mol Pharm       Date:  2017-01-24       Impact factor: 4.939

Review 2.  The expanding role of prodrugs in contemporary drug design and development.

Authors:  Jarkko Rautio; Nicholas A Meanwell; Li Di; Michael J Hageman
Journal:  Nat Rev Drug Discov       Date:  2018-04-27       Impact factor: 84.694

Review 3.  Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents.

Authors:  Michael W Jann; Scott R Penzak
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

Review 4.  Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review.

Authors:  Kunal Maini; Haley Gould; Jessica Hicks; Fatima Iqbal; James Patterson; Amber N Edinoff; Elyse M Cornett; Adam M Kaye; Omar Viswanath; Ivan Urits; Alan D Kaye
Journal:  Neurol Int       Date:  2021-07-01

5.  Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation.

Authors:  Ibrahim M Ibrahim; Aditya N Bade; Zhiyi Lin; Dhruvkumar Soni; Melinda Wojtkiewicz; Bhagya Laxmi Dyavar Shetty; Nagsen Gautam; JoEllyn M McMillan; Yazen Alnouti; Benson J Edagwa; Howard E Gendelman
Journal:  Int J Nanomedicine       Date:  2019-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.